{"product_id":"syncope-and-transient-loss-of-consciousness-9781405176255","title":"Syncope and Transient Loss of Consciousness","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eSyncope is one of the most important causes of transient loss of consciousness, and is such a common event that it may be encountered by practitioners in virtually any field of medicine. As such, a broad spectrum of healthcare professionals may be involved in its assessment and management.\u003cbr\u003e \u003cp\u003eEdited by distinguished individuals whose pioneering work in syncope highlights careers devoted to improving patient care, this book provides:\u003cbr\u003e  Succinct, practical and up-to-date guidance on the optimal clinical evaluation and treatment of patients with syncope and transient loss of consciousness in a multidisciplinary framework\u003cbr\u003e  Evidence-based recommendations founded on comprehensive literature review and extensive clinical experience by expert contributors\u003cbr\u003e  Meaningful clinical tips for appropriate use of guidelines in clinical practice\u003cbr\u003e  Key recent citations\u003cbr\u003e \u003c\/p\u003e \u003cp\u003eBuilding on the European Society of Cardiology Syncope Guidelines, this book provides a clear ev\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eContributors. \u003c\/p\u003e\u003cp\u003ePreface.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1 Syncope and TLOC overview\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003e1 Definition and classification of syncope and transient.\u003c\/p\u003e \u003cp\u003eloss of consciousness.\u003c\/p\u003e \u003cp\u003eJean-Jacques Blanc.\u003c\/p\u003e \u003cp\u003e2 Epidemiologic aspects of transient loss of consciousness\/syncope.\u003c\/p\u003e \u003cp\u003eRobert S Sheldon, Anna Serletis.\u003c\/p\u003e \u003cp\u003e3 Pathophysiology of syncope: postural, neurally-mediated,.\u003c\/p\u003e \u003cp\u003eand arrhythmic.\u003c\/p\u003e \u003cp\u003eW Wieling.\u003c\/p\u003e \u003cp\u003e4 Cerebral perfusion in syncope.\u003c\/p\u003e \u003cp\u003eJ Gert van Dijk, Roland D Thijs.\u003c\/p\u003e \u003cp\u003e5 Risk stratification—impact on diagnostic strategy.\u003c\/p\u003e \u003cp\u003eBrian Olshansky.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2 Clinical evaluation strategies\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003e6 Value and limitations of clinical history in assessing cause of syncope.\u003c\/p\u003e \u003cp\u003ePaolo Alboni, Maurizio Dinelli.\u003c\/p\u003e \u003cp\u003e7 Emergency department evaluation of transient loss of consciousness\/.\u003c\/p\u003e \u003cp\u003esyncope.\u003c\/p\u003e \u003cp\u003eFranc¸ois P Sarasin.\u003c\/p\u003e \u003cp\u003e8 The essential autonomic assessment for evaluating the.\u003c\/p\u003e \u003cp\u003ecause of syncope.\u003c\/p\u003e \u003cp\u003eCarlos A Morillo, Juan C Guzman.\u003c\/p\u003e \u003cp\u003e9 Neurally-mediated reflex syncope: recognition by history and.\u003c\/p\u003e \u003cp\u003eclinical testing.\u003c\/p\u003e \u003cp\u003eAnna Serletis, Robert S Sheldon.\u003c\/p\u003e \u003cp\u003e10 Value and limitations of ambulatory electrocardiographic monitoring.\u003c\/p\u003e \u003cp\u003eAndrew D Krahn.\u003c\/p\u003e \u003cp\u003e11 Recording ambulatory blood pressure in the syncope and.\u003c\/p\u003e \u003cp\u003eTLOC evaluation.\u003c\/p\u003e \u003cp\u003eDietrich Andresen.\u003c\/p\u003e \u003cp\u003e12 Electrophysiologic testing: value and limitations in the transient loss of.\u003c\/p\u003e \u003cp\u003econsciousness\/syncope evaluation.\u003c\/p\u003e \u003cp\u003eSuneet Mittal.\u003c\/p\u003e \u003cp\u003e13 Intolerance to upright posture in autonomic failure and the postural.\u003c\/p\u003e \u003cp\u003etachycardia syndrome: assessment and treatment strategies.\u003c\/p\u003e \u003cp\u003eChristopher J Mathias.\u003c\/p\u003e \u003cp\u003e14 Improving tolerance to upright posture: current status of tilt-training.\u003c\/p\u003e \u003cp\u003eand other physical maneuvers.\u003c\/p\u003e \u003cp\u003eHugo Ector, Tony Reybrouck.\u003c\/p\u003e \u003cp\u003e15 Syncope in patients with bundle-branch block and other conduction.\u003c\/p\u003e \u003cp\u003esystem abnormalities.\u003c\/p\u003e \u003cp\u003eAngel Moya.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3 Specific conditions\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003e16 Treatment strategies in neurally-mediated reflex syncope: effectiveness of.\u003c\/p\u003e \u003cp\u003edrugs, pacing, and physical maneuvers.\u003c\/p\u003e \u003cp\u003eRichard Sutton.\u003c\/p\u003e \u003cp\u003e17 Structural heart disease, syncope, and risk of sudden death: selection of.\u003c\/p\u003e \u003cp\u003epatients for implantable cardioverter-defibrillator therapy.\u003c\/p\u003e \u003cp\u003eKathy L Lee, Hung-Fat Tse, Chu-Pak Lau.\u003c\/p\u003e \u003cp\u003e18 Channelopathies as a cause of syncope.\u003c\/p\u003e \u003cp\u003eT Boussy, Pedro Brugada.\u003c\/p\u003e \u003cp\u003e19 Distinguishing seizures and pseudosyncope from syncope.\u003c\/p\u003e \u003cp\u003eAdam P Fitzpatrick.\u003c\/p\u003e \u003cp\u003e20 Syncope and transient loss of consciousness in children and adolescents:.\u003c\/p\u003e \u003cp\u003econgenital and acquired conditions.\u003c\/p\u003e \u003cp\u003eHugh Calkins.\u003c\/p\u003e \u003cp\u003e21 Transient loss of consciousness, syncope, and falls in the elderly.\u003c\/p\u003e \u003cp\u003eRose Anne Kenny.\u003c\/p\u003e \u003cp\u003e22 Drug-induced (iatrogenic) syncope.\u003c\/p\u003e \u003cp\u003eGerald V Naccarelli.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4 Economic and research aspects\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003e23 Syncope and the competitive athlete: recommendations for evaluation.\u003c\/p\u003e \u003cp\u003eand permission to compete.\u003c\/p\u003e \u003cp\u003eFranco Giada, Antonio Raviele (Ospedale Umberto I).\u003c\/p\u003e \u003cp\u003e24 Role of syncope management units.\u003c\/p\u003e \u003cp\u003eWin K Shen, Michele Brignole (Ospedali del Tigullio).\u003c\/p\u003e \u003cp\u003e25 The impact of syncope and transient loss of consciousness on.\u003c\/p\u003e \u003cp\u003equality of life.\u003c\/p\u003e \u003cp\u003eBlair P Grubb.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 5 Current controversies and future directions\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003e26 Driving and flying restrictions for the syncope and\/or implanted.\u003c\/p\u003e \u003cp\u003ecardiac device patient.\u003c\/p\u003e \u003cp\u003eChristina M Murray, Dwight W Reynolds.\u003c\/p\u003e \u003cp\u003e27 Clinical trials landscape: what’s new, what’s ongoing, what do.\u003c\/p\u003e \u003cp\u003ewe need.\u003c\/p\u003e \u003cp\u003eMichele Brignole (Ospedali del Tigullio), David G Benditt (University of Minnesota Medical School), Wouter Wieling (Academic Medical Centre).\u003c\/p\u003e \u003cp\u003e28 Syncope and transient loss of consciousness: multidisciplinary.\u003c\/p\u003e \u003cp\u003emanagement.\u003c\/p\u003e \u003cp\u003eA John Camm.\u003c\/p\u003e \u003cp\u003e29 Syncope practice guidelines initiative.\u003c\/p\u003e \u003cp\u003eDavid G Benditt (University of Minnesota Medical School).\u003c\/p\u003e \u003cp\u003eAppendix: syncope consortium members.\u003c\/p\u003e \u003cp\u003eIndex\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49407906316631,"sku":"9781405176255","price":84.56,"currency_code":"GBP","in_stock":false}],"url":"https:\/\/bookcurl.com\/products\/syncope-and-transient-loss-of-consciousness-9781405176255","provider":"Book Curl","version":"1.0","type":"link"}